매출 성장 + 마진 확대 + FCF 양수
Positive매출이 +8.3% 성장하면서 영업이익률이 -0.7%에서 6.5%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.
Evidence
매출 YoY +8.3%영업이익률 -0.7%→6.5%FCF 87,680
Kyungin Synthetic
012610 · KOSPI₩3,160+0.00%
2026-09-04 closeKyungin Synthetic last closed at ₩3,160 (+0.00%) on 2026-09-04. Listed on KOSPI; price, financials and dividends update daily after market close.
Loading chart…
Close
No active signal.
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p
Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
B
Overall: 화학 53/109 · top 49%
Factor composite · relative position in sector
PER 8.58 · PBR 0.55 — own-history percentile 91/100 · 92/100
Open self-history band
PER91/100
PBR92/100
Factual information · not investment advice
Past reported results · not investment advice
More — deeper indicators
Annual dividend
Split-adjusted annual DPS history and available grade axes
Paid 30 consecutive years · Raised 0 consecutive years · Yield 1.58% (based on 2025 payment of 50원) · 3-year growth +0.0%
Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024Grey zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 2.51
Distress
Grey
Safe
- Altman Z''
- 2.51
- Beneish M-Score
- -2.93
- Sloan accrual
- -8.79%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
8/9Strong
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score8/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtPass
- Higher current ratioNot passed
- No new sharesPass
Efficiency
- Higher gross marginPass
- Higher asset turnoverPass
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Industry structure
KRAs of 2026-09-05화학
This stock is in 화학: revenue rank 45 of 108, share 0.2%.
45 / 1080.2%revenue share
Who dominates this industry?
- 1LG화학31.9%
- 2롯데케미칼13.3%
- 3금호석유화학4.7%
- 4DL3.7%
- 5코오롱인더3.2%
- 6경인양행0.2%
Concentration
DistributedCR3 49.9%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
MixedConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 8.84
- Direction
- 확대
- Level
- 보통
- Years
- 6
Value lens
- P90/P10
- 9.5
- Median P/B
- 0.68
- Level
- 넓음
- n
- 96
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 6.5%
- Interest coverage
- 2.6x
- Return on equity (ROE)
- 6.4%
Operating margin −5pp
Interest coverage riskInterest coverageBase 2.6x adverse case 0.6x
Return on equity (ROE)Base 6.4% adverse case -1.6%
Revenue −15%
TolerableInterest coverageBase 2.6x adverse case 2.2x
Return on equity (ROE)Base 6.4% adverse case 4.7%
Interest rate +2pp
TolerableInterest coverageBase 2.6x adverse case 1.6x
Return on equity (ROE)Base 6.4% adverse case 3.6%
Interest coverage limit
Current margin 4ppInterest coverage limit at an operating margin of 2.5%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-19Suppliers disclosed by the company in its 2026-03-19 annual report.
Purchase amount
KRW 100m- BASEKRW 960.7B
Suppliers without disclosed amount
ParaACID
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 김흥준33.67%2026-06-02 · 증감 +0.01%p
Connections
AI-extracted related companies · for reference
🔗 See in the full market map →Recent filings
Kyungin Synthetic's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
About Kyungin Synthetic
- What technical signals does Kyungin Synthetic (012610) have?
- Kyungin Synthetic current technical signals: no active technical signal.
- Is Kyungin Synthetic a cup-and-handle pattern?
- No. Kyungin Synthetic has no valid cup-and-handle signal right now.
- What are Kyungin Synthetic's financials and valuation?
- Kyungin Synthetic's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy